Senti Biosciences (SNTI) Short Interest Ratio & Short Volume $1.00 +0.01 (+1.21%) As of 02:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Senti Biosciences Short Interest OverviewAs of April 30, 2026, Senti Biosciences (SNTI) had a short interest of 666,771 shares sold short, representing 2.21% of the public float. This marks a 2.22% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.4, meaning it would take 2.4 days of the average trading volume of 197,050 shares to cover all short positions.Current Short Interest666,771 sharesPrevious Short Interest652,268 sharesChange Vs. Previous Month2.22%Dollar Volume Sold Short$616.70 thousandShort Interest Ratio2.4 Days to CoverLast Record DateApril 30, 2026Outstanding Shares31,145,000 sharesShort Percent of Float2.21%Today's Trading Volume144,908 sharesAverage Trading Volume197,050 sharesToday's Volume Vs. Average74% Short Selling Senti Biosciences? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Senti Biosciences Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2026666,771 shares $616.70 thousand +2.2%2.2%2.36 $0.92 4/15/2026652,268 shares $609.94 thousand -11.4%2.2%6.79 $0.94 3/31/2026736,084 shares $597.70 thousand -2.1%2.4%6.2 $0.81 3/13/2026751,516 shares $700.04 thousand -7.6%3.0%6.42 $0.93 2/27/2026813,632 shares $767.99 thousand -2.9%3.2%5.87 $0.94 2/13/2026838,072 shares $697.28 thousand +11.4%3.3%3.95 $0.83 1/30/2026752,592 shares $752.59 thousand -5.1%3.0%2.55 $1.00 1/15/2026792,811 shares $840.38 thousand -22.3%3.1%2.99 $1.06 12/31/20251,019,881 shares $1.06 million -38.7%4.0%1.99 $1.04 12/15/20251,663,760 shares $2.01 million +458.4%6.5%0.22 $1.21 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/28/2025297,970 shares $657.02 thousand +67.7%1.2%2.6 $2.21 11/14/2025177,642 shares $286.00 thousand -22.4%0.7%2.1 $1.61 10/31/2025228,939 shares $464.75 thousand -1.0%0.9%1.87 $2.03 10/15/2025231,300 shares $534.30 thousand +1.4%3.5%1.2 $2.31 9/30/2025228,100 shares $321.62 thousand -7.2%3.4%0.9 $1.41 9/15/2025245,700 shares $334.15 thousand +2.0%3.1%1 $1.36 8/31/2025240,900 shares $354.12 thousand -21.7%3.0%0.7 $1.47 8/15/2025307,600 shares $467.55 thousand +10.3%3.9%1 $1.52 7/31/2025278,900 shares $474.13 thousand -57.4%3.5%0.9 $1.70 7/15/2025655,200 shares $1.23 million +7.3%8.2%1.9 $1.88 6/30/2025610,700 shares $1.29 million +115.0%7.7%3 $2.11 6/15/2025284,100 shares $738.66 thousand +79.2%3.6%1.5 $2.60 5/31/2025158,500 shares $485.01 thousand +1.9%2.0%1.7 $3.06 5/15/2025155,600 shares $488.58 thousand -38.1%2.0%1.7 $3.14 4/30/2025251,400 shares $834.65 thousand +261.7%3.2%2.7 $3.32 4/15/202569,500 shares $255.07 thousand +13.0%0.9%2.2 $3.67 3/31/202561,500 shares $206.64 thousand +55.3%0.8%1.4 $3.36 3/15/202539,600 shares $138.20 thousand -43.8%0.4%0.6 $3.49 2/28/202570,400 shares $211.90 thousand +2.6%2.2%0.5 $3.01 2/15/202568,600 shares $299.10 thousand -33.9%2.2%0 $4.36 1/31/2025103,800 shares $452.57 thousand +95.5%3.4%0 $4.36 1/15/202553,100 shares $202.31 thousand -16.5%1.8%0 $3.81 12/31/202463,600 shares $223.24 thousand -38.8%2.2%0 $3.51 12/15/2024103,900 shares $578.72 thousand +76.1%3.6%0 $5.57 11/30/202459,000 shares $127.44 thousand +1.7%2.1%0 $2.16 11/15/202458,000 shares $124.70 thousand -10.9%2.0%3.2 $2.15 10/31/202465,100 shares $141.27 thousand +10.0%2.3%2.5 $2.17 10/15/202459,200 shares $120.48 thousand -14.7%2.1%1.4 $2.04 9/30/202469,400 shares $156.84 thousand -0.7%2.4%1.4 $2.26 9/15/202469,900 shares $214.59 thousand -9.5%2.4%0.1 $3.07The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.See the stock Musk's own words pointed to right here 8/31/202477,200 shares $204.58 thousand -30.9%2.7%0.1 $2.65 8/15/2024111,700 shares $255.79 thousand +86.2%4.0%0.2 $2.29 7/31/202460,000 shares $138.60 thousand +38.9%2.2%0.1 $2.31 7/15/202443,200 shares $136.04 thousand -70.6%1.6%0.1 $3.15 6/30/20241,470,000 shares $405.72 thousand +443.0%5.3%0.2 $0.28 6/15/2024270,700 shares $66.70 thousand +8.5%1.0%0.3 $0.25 5/31/2024249,500 shares $74.85 thousand -11.3%0.9%2 $0.30 5/15/2024281,400 shares $106.37 thousand -2.1%1.0%2.6 $0.38 4/30/2024287,300 shares $103.43 thousand +73.9%1.1%2.5 $0.36 4/15/2024165,200 shares $49.76 thousand -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80.62 thousand -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83.25 thousand -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116.06 thousand -21.9%1.0%0.4 $0.43 2/15/2024345,400 shares $146.80 thousand +15.1%1.3%0.5 $0.43 1/31/2024300,000 shares $135.03 thousand -30.4%1.2%0.1 $0.45 1/15/2024430,700 shares $232.15 thousand -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508.13 thousand +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182.99 thousand -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358.70 thousand -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557.70 thousand +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116.54 thousand -8.2%1.6%0.2 $0.28 10/15/2023453,800 shares $137.00 thousand +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93.42 thousand +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122.82 thousand -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203.71 thousand -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242.47 thousand -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322.56 thousand -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298.55 thousand +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214.06 thousand -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402.30 thousand -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407.57 thousand -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502.36 thousand +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493.43 thousand -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541.53 thousand +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596.14 thousand -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705.10 thousand +12.6%2.2%5.4 $1.27 2/28/2023493,100 shares $739.65 thousand -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860.89 thousand -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867.86 thousand +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565.14 thousand -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974.97 thousand -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17 9/15/2022180,100 shares $405.23 thousand -23.0%0.5%0.1 $2.25 8/31/2022234,000 shares $458.64 thousand -16.1%0.7%0.2 $1.96 8/15/2022278,800 shares $568.75 thousand -3.5%0.8%0.2 $2.04The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.See the stock Musk's own words pointed to right here 7/31/2022288,900 shares $904.26 thousand +110.1%0.9%0.2 $3.13 7/15/2022137,500 shares $247.50 thousand No Change0.4%0.4 $1.80 SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 666,771 shares of SNTI short. 2.21% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.4. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.21% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 666,771 shares, an increase of 2.2% from the previous total of 652,268 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Senti Biosciences' short interest compare to its competitors? 2.21% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Senti Biosciences: Alpha Cognition Inc. (0.96%), Turn Therapeutics Inc. (0.17%), Edesa Biotech, Inc. (7.64%), PepGen, Inc. (4.69%), ALT5 Sigma Corporation (12.32%), Biomea Fusion, Inc. (24.34%), Cardiff Oncology, Inc. (29.12%), Kalaris Therapeutics Inc. (10.99%), Cognition Therapeutics, Inc. (10.43%), Oncolytics Biotech Inc. (6.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. SNTI shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is April, 30 2026. What do SNTI's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like SNTI:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies Alpha Cognition Short Interest Turn Therapeutics Short Interest Edesa Biotech Short Interest PepGen Short Interest ALT5 Sigma Short Interest Biomea Fusion Short Interest Cardiff Oncology Short Interest Kalaris Therapeutics Short Interest Cognition Therapeutics Short Interest Oncolytics Biotech Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredMaybe the Greatest Strategy of the DecadeNate Bear, Lead Technical Tactician at Monument Traders Alliance, is going public with his highest-conviction ...Monument Traders Alliance | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?On July 17th, the House passed the GENIUS Act - and at least one prominent Trump ally is raising alarms. Rep. ...Goldco Direct, LLC | SponsoredTo Avoid 67 Million Blackouts, Trump Signs Emergency Backing of New Energy TechPresident Trump has used emergency executive powers to back a new energy technology described as 326 times mor...Altimetry | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
